Ameriprise’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.14M Buy
443,749
+313,160
+240% +$3.63M ﹤0.01% 2337
2025
Q1
$1.14M Buy
+130,589
New +$1.14M ﹤0.01% 3132
2024
Q4
Sell
-77,371
Closed -$1.75M 4130
2024
Q3
$1.75M Buy
77,371
+16,810
+28% +$380K ﹤0.01% 2971
2024
Q2
$1.18M Sell
60,561
-405,793
-87% -$7.89M ﹤0.01% 3093
2024
Q1
$17.5M Sell
466,354
-48,987
-10% -$1.84M ﹤0.01% 1388
2023
Q4
$28.8M Buy
515,341
+500,802
+3,445% +$28M 0.01% 1063
2023
Q3
$600K Sell
14,539
-15,845
-52% -$654K ﹤0.01% 3334
2023
Q2
$1.7M Sell
30,384
-22,736
-43% -$1.27M ﹤0.01% 2957
2023
Q1
$2.96M Sell
53,120
-5,704
-10% -$318K ﹤0.01% 2647
2022
Q4
$2.14M Buy
58,824
+6,057
+11% +$221K ﹤0.01% 2776
2022
Q3
$1.5M Sell
52,767
-4,747
-8% -$135K ﹤0.01% 2911
2022
Q2
$2.6M Sell
57,514
-1,578,382
-96% -$71.5M ﹤0.01% 2708
2022
Q1
$124M Buy
1,635,896
+40,627
+3% +$3.09M 0.04% 451
2021
Q4
$238M Buy
1,595,269
+520,671
+48% +$77.6M 0.07% 309
2021
Q3
$156M Sell
1,074,598
-255,124
-19% -$37.1M 0.05% 392
2021
Q2
$260M Sell
1,329,722
-79,485
-6% -$15.6M 0.08% 260
2021
Q1
$255M Buy
1,409,207
+37,573
+3% +$6.8M 0.08% 239
2020
Q4
$194M Buy
1,371,634
+606,538
+79% +$85.9M 0.07% 294
2020
Q3
$95.4M Buy
765,096
+224,219
+41% +$28M 0.04% 434
2020
Q2
$48.3M Buy
540,877
+347,974
+180% +$31.1M 0.02% 636
2020
Q1
$12M Buy
192,903
+176,093
+1,048% +$11M 0.01% 1257
2019
Q4
$1.28M Buy
16,810
+6,086
+57% +$464K ﹤0.01% 2951
2019
Q3
$540K Buy
+10,724
New +$540K ﹤0.01% 3272